S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
NASDAQ:AVGR

Avinger (AVGR) Competitors

$0.55
+0.03 (+5.79%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.53
$0.56
50-Day Range
$0.43
$0.82
52-Week Range
$0.42
$1.95
Volume
25,454 shs
Average Volume
56,398 shs
Market Capitalization
$5.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AVGR vs. RMED, IGAP, PYPD, BJDX, SINT, AEMD, INVO, INBS, RSLS, and NURO

Should you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Ra Medical Systems (RMED), Integrity Applications (IGAP), PolyPid (PYPD), Bluejay Diagnostics (BJDX), Sintx Technologies (SINT), Aethlon Medical (AEMD), INVO Bioscience (INVO), Intelligent Bio Solutions (INBS), ReShape Lifesciences (RSLS), and NeuroMetrix (NURO). These companies are all part of the "medical" sector.

Avinger vs.

Avinger (NASDAQ:AVGR) and Ra Medical Systems (NYSE:RMED) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, community ranking, institutional ownership, profitability, dividends and analyst recommendations.

Avinger received 302 more outperform votes than Ra Medical Systems when rated by MarketBeat users. Likewise, 62.80% of users gave Avinger an outperform vote while only 57.89% of users gave Ra Medical Systems an outperform vote.

CompanyUnderperformOutperform
AvingerOutperform Votes
390
62.80%
Underperform Votes
231
37.20%
Ra Medical SystemsOutperform Votes
88
57.89%
Underperform Votes
64
42.11%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avinger
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Ra Medical Systems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Avinger has higher revenue and earnings than Ra Medical Systems. Avinger is trading at a lower price-to-earnings ratio than Ra Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avinger$8.27 million0.71-$17.62 million-$3.12-0.18
Ra Medical Systems$10 thousand563.85-$26.86 million-$92.36-0.01

Ra Medical Systems has a net margin of 0.00% compared to Avinger's net margin of -207.02%. Ra Medical Systems' return on equity of -183.58% beat Avinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Avinger -207.02% -530.21% -68.66%
Ra Medical Systems N/A -183.58% -125.90%

14.1% of Avinger shares are held by institutional investors. 0.5% of Avinger shares are held by insiders. Comparatively, 18.6% of Ra Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Ra Medical Systems had 4 more articles in the media than Avinger. MarketBeat recorded 4 mentions for Ra Medical Systems and 0 mentions for Avinger. Avinger's average media sentiment score of 0.00 equaled Ra Medical Systems' average media sentiment score.

Company Overall Sentiment
Avinger Neutral
Ra Medical Systems Neutral

Summary

Avinger beats Ra Medical Systems on 8 of the 14 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVGR vs. The Competition

MetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$5.86M$3.66B$4.62B$6.27B
Dividend YieldN/A3.08%2.32%6.39%
P/E Ratio-0.1827.0282.9412.22
Price / Sales0.7131.653,595.9699.65
Price / CashN/A66.3092.03105.95
Price / Book-3.915.265.176.89
Net Income-$17.62M$59.74M$117.97M$193.40M
7 Day Performance-3.18%2.30%1.97%2.27%
1 Month Performance27.44%-0.30%2.30%5.07%
1 Year Performance-68.86%-8.39%12.37%1.69%

Avinger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMED
Ra Medical Systems
0 of 5 stars
$1.12
-6.7%
N/A-93.6%$6.01M$10,000.00-0.0158News Coverage
High Trading Volume
IGAP
Integrity Applications
0 of 5 stars
$0.44
-6.4%
N/A-85.2%$6.77MN/A0.0011Gap Down
High Trading Volume
PYPD
PolyPid
2.2396 of 5 stars
$0.35
-2.8%
$10.50
+2,898.3%
-91.9%$6.85MN/A-0.2175Positive News
Gap Up
BJDX
Bluejay Diagnostics
1.7509 of 5 stars
$0.28
+22.2%
N/A-75.8%$5.63M$250,000.00-0.569Analyst Revision
Gap Down
High Trading Volume
SINT
Sintx Technologies
1.8611 of 5 stars
$1.38
-7.4%
$136.00
+9,755.1%
-96.9%$5.41M$1.56M0.0036Gap Down
AEMD
Aethlon Medical
1.4934 of 5 stars
$0.32
flat
N/A-75.0%$7.43M$290,000.00-0.4410News Coverage
INVO
INVO Bioscience
0 of 5 stars
$0.36
+5.9%
$3.00
+735.4%
-75.5%$5.02M$820,000.00-0.4110
INBS
Intelligent Bio Solutions
0 of 5 stars
$2.76
-8.0%
N/AN/A$4.78M$440,000.000.00N/APositive News
Gap Down
RSLS
ReShape Lifesciences
0 of 5 stars
$2.69
flat
$47.75
+1,672.5%
-94.5%$7.92M$11.24M0.0047
NURO
NeuroMetrix
0 of 5 stars
$1.03
-5.5%
N/A-75.8%$8.08M$8.26M-1.4923Analyst Report
Gap Down

Related Companies and Tools

This page (NASDAQ:AVGR) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -